Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
The Cochrane Database of Systematic Reviews|January 22, 2010
Antigen-specific active immunotherapy for ovarian cancerNinke Leffers, Toos Daemen, Wijnand Helfrich, et al.
Lasers in Surgery and Medicine|September 2, 2014
Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cellsWei Peng, Douwe F Samplonius, Sebastiaan de Visscher, et al.
The Journal of Investigative Dermatology|May 26, 2019
Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint BlockadeIris Koopmans, Mark A J M Hendriks, Robert J van Ginkel, et al.
The Cochrane Database of Systematic Reviews|September 18, 2014
Antigen-specific active immunotherapy for ovarian cancerNinke Leffers, Toos Daemen, Wijnand Helfrich, et al.
Oncoimmunology|December 10, 2020
Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα "don't eat me" immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentationMark A J M Hendriks, Emily M Ploeg, Iris Koopmans, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 25, 2008
Potent systemic anticancer activity of adenovirally expressed EGFR-selective TRAIL fusion proteinEdwin Bremer, Gooitzen M van Dam, Marco de Bruyn, et al.
Cancer Letters|July 13, 2014
A CSPG4-specific immunotoxin kills rhabdomyosarcoma cells and binds to primary tumor tissuesHannes Brehm, Judith Niesen, Radoslav Mladenov, et al.
Oncoimmunology|September 18, 2018
A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpointIris Koopmans, Djoke Hendriks, Douwe F Samplonius, et al.
Oncoimmunology|September 14, 2016
Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis inductionDjoke Hendriks, Yuan He, Iris Koopmans, et al.
Oncoimmunology|December 3, 2021
Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axisMark A J M Hendriks, Isabel Britsch, Xiurong Ke, et al.
Pageof 8